Researchers from the department of Endocrinology & Diabetes at Perth Children’s Hospital and the Children's Diabetes Centre at The Kids Institute Australia (The Kids) are looking for healthy adults aged 18 – 60 years to be involved in a new study investigating the action of one dose of oral semaglutide.
Semaglutide is a medication used in Type 2 diabetes management and can also help with weight loss. We want to see how a single dose of semaglutide in a capsule form will affect blood glucose and insulin responses in healthy adults.
Semaglutide is currently only available as a subcutaneous injection, and this study is an important step towards an alternative oral capsule treatment for patients.
Who can participate in the study?
Healthy adults aged 18-60 with no medical conditions.
Find out more about the study:
If you are interested, or would like more information, please email diabetes.research@health.wa.gov.au